Interaction between pefloxacin and aminophylline in genetically epilepsy-prone rats

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 10, 1997, Pages 1025-1029

  Imperatore, C ^a   Trimarchi, G R ^a   De Sarro, A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINOPHYLLINE; EXCITATORY AMINO ACID; PEFLOXACIN; PURINE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; EPILEPSY; GENETIC PREDISPOSITION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SEIZURE;

EID: 0030664230     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06035.x     Document Type: Article

References (33)

1. Akahane, K., Sekiguchi, M., Une, T., Osada, Y. (1989) Structure-epileptogenicity relationship of quinolones with special reference to their interaction with garama-aminobutyric acid receptor sites. Antimicrob. Agents Chemother. 33: 1704-1707
2. Ball, P. (1986) Ciprofloxacin: an overview of adverse experiences. J. Antimicrob. Chemother. 18: 187-193
3. Corradetti, R., Lo Conte, R., Moroni, F., Passani, M. B., Pepeu, G. (1984) Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. Pharmacol. 104: 19-26
4. Dalhoff, A. (1989) A review of quinolone tissue pharmacokinetics. In: Fernandes P. B. (ed.) Quinolones. J. R. Prous Science Publishers S. A., Barcelona, pp 277-312
5. Daly, J. M., Bruns, R. F., Snyder, S. H. (1981) Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. Life Sci. 28: 2083-2097
6. De Sarro, A., De Sarro, G. B. (1991) Responsiveness of genetically epilepsy-prone rats to aminophylline-induced seizures and interactions with quinolones. Neuropharmacology 30: 169-176
7. Dimpfel, W., Spuler, M., Dalhoff, A., Hoffman, W., Schluter, G. (1991) Hippocampal activity in the presence of quinolones and fenbufen in vitro. Antimicrob. Agents Chemother. 35: 1142-1146
8. Dunwiddie, T. V., Hoffer, B. J., Fredholm, B. B. (1981) Alkylxanthines elevate hippocampal excitability. Naunyn-Schmiedebergs Arch. Pharmacol. 316: 326-330
9. Faingold, C. L. (1988) The genetically epilepsy-prone rat. Gen. Pharmacol. 19: 331-338
10. Frank, J. E., Ginter, K. L., Schwartzkroin, P. A. (1989) Developing genetically epilepsy-prone rats have an abnormal seizure response. Epilepsia 30: 1-6
11. Fredholm, B. B., Hedqvist, P. (1980) Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem. Pharmacol. 29: 1635-1645
12. Gomeni, C., Gomeni, R. (1978) IGPHARM: interactive graphic package for pharmacokinetic analysis. Comp. Biomed Res. 11: 345-361
13. Gonzalez, I. P., Henwood, I. M., (1989) Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 37: 717-721
14. Hasegawa, T., Nadai, M., Kuzuya, T., Muraoka, I., Apichartpichean, R., Takagi, K., Miyamoto, K. (1990) The possible mechanism of interaction between xanthines and quinolones. J. Pharm. Pharmacol. 42: 767-772
15. Ho, G., Tierney, M. G., Dales, R. E. (1988) Evaluation of the effect of norfloxacin on the pharmacokinetics of theophylline. Clin. Pharmacol. Ther. 44: 35-38
16. Imperatore, C., De Sarro, G. B., De Luca, R., Trimarchi, G. R., De Sarro, A., Costa, G. (1995) Differences in the pharmacokinetics of aminophylline between genetically epilepsy-prone and normal Sprague-Dawley rats. Pharm. Sci. 1: 145-149
17. Laird, H., Jobe, P. C. (1987) The genetically epilepsy-prone rat. In: Jobe, P. C., Laird, H. (eds) Neurotransmitters and Epilepsy. Humana Press, Clifton, NJ, pp 57-89
18. Maesen, F. P. V., Teengs, J. P., Baur, C., Davies, B. I. (1984) Quinolones and raised plasma concentrations of theophylline. Lancet 2: 530
19. Montay, G., Goueffon, Y., Roquet, F. (1984) Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans. Antimicrob. Agents Chemother. 25: 463-472
20. Mulder, G. J., Nagelkerke, J. F., Tijdens, R. B., Wijands, W. J. A., Van Der Mark, E. J. (1988) Inhibition of the oxidative metabolism of theophylline in isolated rat hepatocytes by the quino-lone antibiotic enoxacin and its metabolite oxo-enoxacin, butnot by ofloxacin. Biochem Pharmacol. 37: 2565-2568
21. Neu, H. C. (1987) Clinical use of the quinolones. Lancet 82: 1319-1322
22. Nix, D. E., Norman, A., Schentag, J. J. (1989) Effect of lomefloxacin on theophylline pharmacokinetics. Antimicrob. Agents Chemother. 33: 1006-1008
23. Raoof, S., Wollschlager, C., Faroque, A. K. (1987) Ciprofloxacin increases serum levels of theophylline. Am. J. Med. 82: 115-118
24. Reigel, C. E., Dailey, J. W., Jobe, P. C. (1986) Neurobiology of seizure predisposition - the genetically epilepsy-prone rat. I. The genetically epilepsy-prone rat: an overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs. Life Sci. 39: 763-774
25. Rogge, M. C., Solomon, W. R., Sedman, A. J., Welling, P. G., Toothaker, R. D., Wagner, J. G. (1988) The theophylline-enoxacin interaction: 1. effect of enoxacin dose size on theophylline disposition. Clin. Pharmacol. Ther. 44: 579-587
26. Ryder, K., Glick, M. R., Opheim, K. E., Hood, L., Roullet, A., Bienvenu, J., Ou, C. N. (1983) An evaluation of the theophylline method and calibrator for the Du Pont ACA Discrete Clinical Analyzer, Du Pont Company, Willington, DE
27. Sarkar, M., Polk, R. E., Guzelian, P. S., Hunt, C., Karnes, H. T. (1990) In vitro effect of fluoroquinolones on theophylline metabolism. Antimicrob. Agents Chemother. 34: 594-599
28. Segev, S., Rehavi, M., Rubistein, E. (1988) Quinolones, theophylline and diclofenac interactions with the gamma-aminobutyric acid receptor. Antimicrob. Agents Chemother. 32: 4-6
29. Stone, T. W. (1982) Quinolinic acid and kynurenic acid. Trends Pharmacol. Sci. 5: 215
30. Tsuji, A., Sato, H., Kume, Y., Tamai, J., Okezaki, E., Nagata, O., Kato, H. (1988) Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob. Agents Chemother. 32: 190-194
31. A-receptor complex. Br. J. Clin. Pharmacol. 30: 63-70
32. Wijnands, W. J. A., Vree, T. B., Van Herwaarden, C. L. A. (1986) The influence of quinolone derivative on theophylline clearance. Br. J. Clin. Pharmacol. 22: 677-683
33. William, P. D., Helton, D. R. (1991) The propulsive activity of quinolone antibiotics in an animal model. Toxicol. Lett. 58: 23-28